JUAN FRANCISCO
ARENILLAS LARA
CATEDRATICOS DE UNIVERSIDAD
![Foto de José Antonio](/img/nophoto.png)
José Antonio
Castillo Sánchez
Publicacions en què col·labora amb José Antonio Castillo Sánchez (20)
2022
-
A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype
Frontiers in Cardiovascular Medicine, Vol. 9
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
2021
-
Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis
Journal of Clinical Medicine, Vol. 10, Núm. 14
-
Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma
Brain, Vol. 144, Núm. 8, pp. 2416-2426
2014
2013
-
Guías de actuación clínica en la hemorragia intracerebral
Neurologia
-
Los costes del ictus en España según su etiología. El protocolo del estudio CONOCES
Neurologia, Vol. 28, Núm. 6, pp. 332-339
2012
2011
-
Plan de asistencia sanitaria al ICTUS II. 2010
Neurologia, Vol. 26, Núm. 7, pp. 383-396
2009
-
The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men
Stroke, Vol. 40, Núm. 2, pp. 344-349
2008
-
Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment
Disease Markers, Vol. 25, Núm. 3, pp. 181-188
-
Body temperature and response to thrombolytic therapy in acute ischaemic stroke
European Journal of Neurology, Vol. 15, Núm. 12, pp. 1384-1389
-
Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke
Neurology, Vol. 71, Núm. 3, pp. 190-195
2007
-
Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke
Stroke, Vol. 38, Núm. 1, pp. 90-95
-
Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study
Stroke, Vol. 38, Núm. 6, pp. 1855-1859
-
The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome
Stroke, Vol. 38, Núm. 10, pp. 2759-2764
-
The role of angiogenesis in damage and recovery from ischemic stroke
Current Treatment Options in Cardiovascular Medicine, Vol. 9, Núm. 3, pp. 205-212